HR Execs on the Move

First Choice Healthcare

www.1stchoicehealthcare.com

 
First Choice Healthcare is a Macon, GA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Kindbridge Behavioral Health

Kindbridge Behavioral Health is a company that provides online mental health services across the USA with a focus on gambling and gaming disorder treatment and therapy.

Ccs

Ccs is a Woburn, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Valify

Drive tangible savings to your bottom line in weeks versus months using Valify, the only SaaS analytics and benchmarking tool for Purchased Services. Leave manual data aggregation behind. Automate the discovery of opportunity and begin tracking performance so your team can focus on realizing savings.

Brooks Rehabilitation

Our foundation supports many programs throughout the Brooks System of Care, including clinical research, adaptive sports and wellness, school re-entry, and free care for those who need it most. Our Volunteer Services department provides an opportunity for personal growth, education, and service to others. Our goal is to meet the needs of our volunteers while carrying out our vision of providing world-class service to our patients. Volunteer assignments are made according to interest, availability, and the skills needed to fulfill task requirements.

Celator Pharmaceuticals

Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve outcomes for patients with cancer. The Company is working to establish a new treatment paradigm in which rationally-designed, fully-integrated combination products replace combination regimens of individual agents. Celator`s proprietary technology platform, CombiPlex®, identifies the most effective synergistic ratio of the component drugs, optimizes the pharmacology of the drug combination prior to human clinical trials, allows simultaneous administration of the components as a single product and maintains the synergistic ratio of the components after administration thereby exposing tumor cells to the right amounts of drug for the right length of time.